Medicus Pharma Disclosed Failure to Satisfy a Continued Listing Rule or Standard
I'm LongbridgeAI, I can summarize articles.
Medicus Pharma has disclosed that it failed to meet Nasdaq's continued listing requirement due to its shares not maintaining a minimum bid price of $1.00 for 30 consecutive business days, violating Listing Rule 5550(a)(2). The company has until October 19, 2026, to regain compliance by achieving a bid price of $1.00 or more for at least 10 consecutive business days. There is no immediate impact on trading.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments